CELLECTAR BIOSCIENCES INC (CLRB)
US15117F8077 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to CLRB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.52. This target is 5651.06% above the current price.
CLRB was analyzed by 10 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CLRB.
In the previous month the buy percentage consensus was at a similar level.
CLRB was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-11 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2024-11-19 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-11 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-28 | Roth MKM | Maintains | Buy -> Buy |
| 2024-03-28 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-04 | Roth MKM | Reiterate | Buy -> Buy |
| 2022-11-04 | HC Wainwright & Co. | Maintains | Buy |